CRP and fibrinogen imply clinical outcome of patients with Type-2 diabetes and coronary artery disease

Acta Biochimica et Biophysica Sinica

Volumn 49, Issue 3, 2017, Pages 284-285

  Bosevski, Marijan ^a   Bosevska, Golubinka ^a   Stojanovska, Lily ^b   Apostolopoulos, Vasso ^b  

^a SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

^b VICTORIA UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN;

ANGINA PECTORIS; BLOOD; COMPLICATION; CORONARY ARTERY DISEASE; HUMAN; INFLAMMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; PROSPECTIVE STUDY;

ANGINA PECTORIS; BIOMARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FIBRINOGEN; HUMANS; INFLAMMATION; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 85020097701     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmw135     Document Type: Article

References (10)

1. Colwell JA, Lopes-Virella M, Halushka PV. Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care 1981, 4: 121-133.
2. Sander D, Schulze-Horn C, Bickel H, Gnahn H, Bartels E, Conrad B. Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study. Stroke 2006, 37: 351-357.
3. Apostolopoulos V, Borkoles E, Polman R, Stojanovska L. Physical and immunological aspects of exercise in chronic diseases. Immunotherapy 2014, 6: 1145-1157.
4. Stojanovska L, Apostolopoulos V, Polman R, Borkoles E. To exercise, or, not to exercise, during menopause and beyond. Maturitas 2014, 77: 318-323.
5. Bosevski M, Stojanovska L, Apostolopoulos V. Inflammatory biomarkers: impact for diabetes and diabetic vascular disease. Acta Biochim Biophy Sin 2015, 47: 1029-1031.
6. Kahn SE, Zinman B, Haffner SM, O'Neill MC, Kravitz BG, Yu D, Freed MI, et al. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 2006, 55: 2357-2364.
7. Ziegler D. Type 2 diabetes as an inflammatory cardiovascular disorder. Curr Mol Med 2005, 5: 309-322.
8. Ahmad J, Ahmned F, Siddiqui MA, Khan AR, Katyal P, Hameed B, Ahmad I. Inflammatory markers, insulin resistance and carotid intimamedia thickness in North-Indian type 2 diabetic subjects. J Assoc Physicians India 2007, 55: 693-699.
9. Lepojarvi ES, Piira OP, Kiviniemi AM, Miettinen JA, Kentta T, Ukkola O, Tulppo MP, et al. Usefulness of highly sensitive troponin as a predictor of short-term outcome in patients with diabetes mellitus and stable coronary artery disease (from the ARTEMIS Study). Am J Cardiol 2016, 117: 515.
10. Bosevski M, Bosevska G, Stojanovska L. Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: A preliminary report. Cardiovasc Diabetol 2013, 12: 29.